SMARCA5, the other core ATPase subunit, is frequently overexpressed in various tumors, including in breast cancer [58], gastric cancer [59], acute myeloid leukemia (AML) [60], and pancreatic ductal adenocarcinoma (PDAC) [61]. Here, SMARCA5 is linked to breast cancer.